from the ASX...Mt Marion Lithium Project production of 108,696dmt was 16% lower than Q2 FY21 because of lower yielding ore being used in production, as part of the optimised long-term mine plan. Production was up 22% pcp. Shipments of spodumene concentrate were back in line with expectations and the mine remains on track to meet or exceed shipment guidance for FY21 of 450kt to 475kt.
Construction by Albemarle Corporation (NYSE: ALB)(Albemarle) of the 50ktpa Kemerton Lithium Hydroxide Plant continued,with a workforce of approximately 1,250 people on site. The project remains on track for completion in the second half of calendar year 2021.
Record spodumene production 262kdmt, up 36% pcp.
Best ever cost performance $457/dmt, down 11% pcp.
Kemerton hydroxide plant construction progressing well.
Mt Marion Lithium Project continued to deliver in line with the optimised mine plan with production of 129,000 dmt. Shipments of spodumene concentrate were lower during the quarter with one shipment delayed into the current quarter.
Construction by Albemarle Corporation of the 50ktpa Kemerton Lithium Hydroxide Plant continued, with a workforce of approximately 1,250 people on site. The project remains on track for completion in the second half of 2021.
Mt Marion Lithium Project achieved record production of 133,000 dmt and record shipments of 118,000 dmt of spndumene concentrate during the quarter.
Mt Marion Lithium Project achieved record production of 146,000 wmt and record shipments of 114,000 wmt of spodumene concentrate during the quarter.
